CRISPR THERAPEUTICS AG COM CHF0.03 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0VRQ for the last quarter is 504.00 k USD, and it's 99.75% lower compared to the previous quarter. The net income of Q1 24 is -116.59 M USD.